Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR (Q36209104)

12 August 2017

Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR (English)

1 reference

12 August 2017

7

Robert M Califf

1 reference

12 August 2017

5

Donal Reddan

1 reference

12 August 2017

Jula K Inrig

1

1 reference

12 August 2017

Shelly Sapp

2

1 reference

12 August 2017

Huiman Barnhart

3

1 reference

12 August 2017

Uptal D Patel

4

1 reference

12 August 2017

Ajay Singh

6

1 reference

12 August 2017

Lynda Szczech

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

9 May 2012

1 reference

Nephrology Dialysis Transplantation

12 August 2017

1 reference

12 August 2017

27

1 reference

12 August 2017

9

1 reference

12 August 2017

3606-3614

1 reference

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Effects of erythropoietin on blood pressure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Erythropoietin depresses nitric oxide synthase expression by human endothelial cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

In vivo and in vitro pressor effects of erythropoietin in rats

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Hemoglobin variability and mortality in ESRD.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

The relation between pulse pressure and cardiovascular mortality in 12,763 middle-aged men from various parts of the world: a 25-year follow-up of the seven countries study

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Epoetin requirements predict mortality in hemodialysis patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Akaike's information criterion in generalized estimating equations.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433928

Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure

22 September 2018

1 reference

12 December 2020

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis

1 reference

12 December 2020

Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study

1 reference

12 December 2020

Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group

1 reference

12 December 2020

Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group

1 reference

12 December 2020

Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients

1 reference

12 December 2020

Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells

1 reference

12 December 2020

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

12 December 2020

Association of Hemoglobin Delivery With Left Ventricular Structure and Function in Hypertensive Patients

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

Erythropoiesis-stimulating agents--time for a reevaluation

1 reference

12 December 2020

The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFS123

1 reference

12 August 2017

1 reference

12 August 2017

1 reference